Shares of Addus HomeCare (NASDAQ:ADUS) have been assigned a consensus rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $48.00.
Several analysts have recently commented on the stock. Stephens set a $56.00 price target on shares of Addus HomeCare and gave the company a “buy” rating in a research note on Monday, April 2nd. BidaskClub raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 30th. Robert W. Baird set a $43.00 price objective on shares of Addus HomeCare and gave the company a “hold” rating in a research note on Wednesday, March 14th. Finally, Zacks Investment Research raised shares of Addus HomeCare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 9th.
Shares of ADUS traded down $0.15 during mid-day trading on Monday, hitting $52.10. 51,810 shares of the company traded hands, compared to its average volume of 39,991. Addus HomeCare has a one year low of $30.70 and a one year high of $53.35. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.90 and a quick ratio of 2.90. The stock has a market capitalization of $607.71, a P/E ratio of 35.93, a price-to-earnings-growth ratio of 1.90 and a beta of -0.43.
Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, March 5th. The company reported $0.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.03. Addus HomeCare had a net margin of 3.20% and a return on equity of 9.95%. The business had revenue of $111.96 million for the quarter, compared to analysts’ expectations of $110.82 million. analysts anticipate that Addus HomeCare will post 1.83 EPS for the current year.
In other Addus HomeCare news, EVP Darby Anderson sold 883 shares of the firm’s stock in a transaction that occurred on Wednesday, March 14th. The shares were sold at an average price of $43.25, for a total value of $38,189.75. Following the transaction, the executive vice president now directly owns 28,718 shares of the company’s stock, valued at $1,242,053.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 749 shares of the firm’s stock in a transaction that occurred on Monday, January 22nd. The shares were sold at an average price of $38.85, for a total transaction of $29,098.65. Following the completion of the transaction, the chief executive officer now directly owns 33,120 shares in the company, valued at $1,286,712. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,109 shares of company stock worth $258,061. Insiders own 35.80% of the company’s stock.
Hedge funds have recently made changes to their positions in the business. MetLife Investment Advisors LLC bought a new position in Addus HomeCare in the fourth quarter valued at approximately $146,000. First Trust Advisors LP bought a new position in shares of Addus HomeCare during the third quarter worth $207,000. The Manufacturers Life Insurance Company boosted its position in shares of Addus HomeCare by 8.5% during the second quarter. The Manufacturers Life Insurance Company now owns 6,614 shares of the company’s stock worth $246,000 after purchasing an additional 517 shares in the last quarter. Goldman Sachs Group Inc. bought a new position in shares of Addus HomeCare during the fourth quarter worth $258,000. Finally, Los Angeles Capital Management & Equity Research Inc. boosted its position in shares of Addus HomeCare by 46.3% during the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 10,393 shares of the company’s stock worth $367,000 after purchasing an additional 3,290 shares in the last quarter. 59.48% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: “Addus HomeCare (ADUS) Given Average Rating of “Buy” by Brokerages” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/09/addus-homecare-adus-given-average-rating-of-buy-by-brokerages.html.
About Addus HomeCare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.